CODX vs HOLX · rev $3.9M vs P/E 32, rev $4.10B
Co-Diagnostics, Inc. Common Stock (CODX) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
CODX currently screens at market cap $31.4M. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the CODX and HOLX stock pages for the full models.
Not investment advice.